Filters
Catalog peptides
Synthesis of unnatural amino acids and other blocks

C-Type Natriuretic Peptide (1-22), human

Name
C-Type Natriuretic Peptide (1-22), human
Molecular structural formula
Purity
≥95%
CAS Number
127869-51-6
Formula
C93H157N27O28S3
MW
2197.64
Target
others
Sequence
Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys(Disulfide bridge:Cys6-Cys22)
Sequence Shortening
GLSKGCFGLKLDRIGSMSGLGC (Disulfide bridge: Cys6-Cys22)
InChIKey
UHSBKBYWHCBDCJ-DYGWFTAGSA-N
References
[1]. Morozumi N, et al. ASB20123: A novel C-type natriuretic peptide derivative for treatment of growth failure and dwarfism. PLoS One. 2019 Feb 22;14(2):e0212680. [2]. Buckley MG, et al. Circulating C-type natriuretic peptide is increased in orthotopic cardiac transplant recipients and associated with cardiac allograft vasculopathy. Clin Sci (Lond). 2000 Nov;99(5):467-72. [3]. Mazarati AM, et al. ANP(1-28), BNP(1-32) and CNP(1-22) increase the severity of picrotoxin-kindled seizure syndrome in rats. Life Sci. 1993;52(3):PL19-24
* All products on our website are for scientific research and cannot be used in human body
Product details
Data download

C-Type Natriuretic Peptide (CNP) (1-22), human, a 1-22 fragment of CNP, is a natriuretic peptide receptor B (NPR-B) agonist. C-Type Natriuretic Peptide (CNP) (1-22), human inhibits cAMP synthesis stimulated by the physiological agonists histamine and 5-HT or directly by Forskolin. CNP is a potent, endothelial-derived relaxant and growthinhibitory factor.